Memantine acts as a cholinergic stimulant in the mouse hippocampus

Journal of Alzheimer's Disease

Volumn 12, Issue 4, 2007, Pages 319-333

  Drever, Benjamin D ^a   Anderson, William G L ^a   Johnson, Helena ^a   O'Callaghan, Matthew ^a   Seo, Sangwon ^a,b   Choi, Deog Young ^b   Riedel, Gernot ^a   Platt, Bettina ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b LG Chemical Ltd   (South Korea)

Author keywords

Acetylcholine; Alzheimer's disease; Learning; LTP; Muscarinic; Neuroprotection; NMDA; Synaptic transmission

Indexed keywords

BICUCULLINE; CALCIUM ION; CARBACHOL; DIZOCILPINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HIPPOCAMPUS; MAZE TEST; MOUSE; NERVE CELL CULTURE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

EID: 38049069930     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-12405     Document Type: Article

References (78)

1. J.P. Apland and F.J. Cann, Anticonvulsant effects of memantine and MK-801 in guinea pig hippocampal slices, Brain Res Bull 37 (1995), 311-316.
2. Y. Aracava, E.F. Pereira, A. Maelicke and E.X. Albuquerque, Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons, J Pharmacol Exp Ther 312 (2005), 1195-1205.
3. V.B. Aramakis, A.E. Bandrowski and J.H. Ashe, Role of muscarinic receptors, G-proteins, and intracellular messengers in muscarinic modulation of NMDA receptor-mediated synaptic transmission, Synapse 32 (1999), 262-275.
4. V.L. Arvanov, H.C. Chou, R.C. Chen and M.C. Tsai, Presynaptic and postsynaptic actions of memantine at cholinergic central synapse of Achatina-fulica, Comp Biochem Physiol 107 (1994), 305-311.
5. J.M. Auerbach and M. Segal, Muscarinic receptors mediating depression and long-term potentiation in rat hippocampus, J Physiol 492 (1996), 479-493.
6. J.M. Auerbach and M. Segal, A novel cholinergic induction of long-term potentiation in rat hippocampus, J Neurophysiol 72 (1994), 2034-2040.
7. C.A. Barnes, W. Danysz and C.G. Parsons, Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats, Eur J Neurosci 8 (1996), 565-571.
8. R.T. Bartus, R.L. Dean, B. Beer and A.S. Lippa, The cholinergic hypothesis of geriatric memory dysfunction, Science 217 (1982), 408-414.
9. J. Bormann, Memantine is a potent blocker of N-methyl-Daspartate (NMDA) receptor channels, Eur J Pharmacol 166 (1989), 591-592.
10. I. Bresink, T.A. Benke, V.J. Collett, A.J. Seal, C.G. Parsons, J.M. Henley and G.L. Collingridge, Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells, Br J Pharmacol 119 (1996), 195-204.
11. B. Buisson and D. Bertrand, Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor, Mol Pharm 53 (1998), 555-563.
12. H.S. Chen, Y.F. Wang, P.V. Rayudu, P. Edgecomb, J.C. Neill, M Segal, S.A. Lipton and F.E. Jensen, Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation, Neurosci 86 (1998), 121-1132.
13. C.W. Cotman, D.T. Monaghan and A.H. Ganong, Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity, Annu Rev Neurosci 11 (1988), 61-80.
14. C.E. Creeley, D.F. Wozniak, J. Labruyere, G.T. Taylor and J.W. Olney, Low doses of memantine disrupt memory in adult rats, J Neurosci 26 (2006), 3923-3932.
15. C.E. Creeley, D.F. Wozniak, A. Nardi, N.B. Farber and J.W. Olney, Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain, Neurobiol Aging (2007), in press.
16. F. Dajas-Bailador and S. Wonnacott, Nicotinic acetylcholine receptors and the regulation of neuronal signalling, Trends Pharm Sci 25 (2004), 317-324.
17. W. Danysz, C.G. Parsons, J. Kornhuber, W.J. Schmidt and G. Quack, Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies, Neurosci Biobehav Rev 21 (1997), 455-468.
18. W. Dimpfel, Effects of memantine on synaptic transmission in the hippocampus in vitro, Arzneimittelforschung 45 (1995), 1-5.
19. R.S. Doody, Current treatments for Alzheimer's disease: cholinesterase inhibitors, J Clin Psychiatry 64 (2003), 11-17.
20. A.J. Drysdale, D. Ryan, R.G. Pertwee and B. Platt, Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells, Neuropharmacol 50 (2006), 621-631.
21. J. Espinosa-Raya, M. Espinoza-Fonseca, O. Picazo and J. Trujillo-Ferrara, Effect of a M1 allosteric modulator on scopolamine-induced amnesia, Med Chem 3 (2007), 7-11.
22. D. Ferger and J. Krieglstein, Determination of intracellular Ca2+ concentration can be a useful tool to predict neuronal damage and neuroprotective properties of drugs, Brain Res 732 (1996), 87-94.
23. V. Ferretti, F. Sargolini, A. Oliverio, A. Mele and P. Roullet, Effects of intra-accumbens NMDA and AMPA receptor antagonists on short-term spatial learning in the Morris water maze task, Behav Brain Res 179 (2007), 43-49.
24. S. Ferris, L. Schneider, M. Farmer, G. Kay and T. Crook, A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI), Int J Geriatr Psychiatry 22 (2006), 448-455.
25. T. Frankiewicz, A. Pilc and C.G. Parsons, Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices, Neuropharmacol 39 (2000), 631-642.
26. T. Frankiewicz and C.G. Parsons, Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices, Neuropharmacol 38 (1999), 1253-1259.
27. T. Frankiewicz, B. Potier, Z.I. Bashir, G.L. Collingridge and C.G. Parsons, Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices, Br J Pharmacol 117 (1996), 689-697.
28. J. Harvey, R. Balasubramaniam and G.L. Collingridge, Carbachol can potentiate N-methyl-D-aspartate responses in the rat hippocampus by a staurosporine and thapsigargin-insensitive mechanism, Neurosci Lett 162 (1993), 165-168.
29. M.G. Giovannini, D. Mutolo, L. Bianchi, A. Michelassi and G. Pepeu, NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: A microdialysis study, J Neurosci 14 (1994), 1358-1365.
30. M.R. Hynd, H.L. Scott and P.R. Dodd, Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease, Neurochem Int 45 (2004), 583-595.
31. D.J. Koss, K.P. Hindley, G. Riedel and B. Platt, Modulation of hippocampal calcium signalling and plasticity by serine/threonine protein phosphatases, J Neurochem 102 (2007), 1009-1023.
32. A.I. Levey, S.M. Edmunds, V. Koliatsos, R.G. Wiley and C.J. Heilman, Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation, J Neurosci 15 (1995), 4077-4092.
33. P.R. Lewis and C.C. Shute, The cholinergic limbic system: projections to hippocampal formation, medial cortex, nuclei of the ascending cholinergic reticular system, and the subfornical organ and supra-optic crest, Brain 90 (1967), 521-540.
34. H. Markram and M. Segal, The inositol 1,4,5-trisphosphate pathway mediates cholinergic potentiation of rat hippocampal neuronal responses to NMDA, J Physiol 447 (1992), 513-533.
35. P.D. Maskell, P. Speder, N.R. Newberry and I. Bermudez, Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors, Br J Pharmacol 140 (2003), 1313-1319.
36. E. Masliah, M. Alford, R. DeTeresa, M. Mallory and L. Hansen, Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease, Ann Neurol 40 (1996), 759-766.
37. M.P. Mattson, Pathways towards and away from Alzheimer's disease, Nature 430 (2004), 631-639.
38. M. McKinney, J.H. Miller and P.J. Aagaard, Pharmacological characterization of the rat hippocampal muscarinic autoreceptor, J Pharmacol Exp Ther 264 (1993), 74-78.
39. R. McShane, A. Areosa Sastre and N. Minakaran, Memantine for dementia, Cochrane Database Syst Rev 2(2) (2006), CD003154.
40. J.J. Miguel-Hidalgo, X.A. Alvarez, R. Cacabelos and G. Quack, Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40), Brain Res 958 (2002), 210-221.
41. T.A. Milner, R. Loy and D.G. Amaral, An anatomical study of the development of the septo-hippocampal projection in the rat, Brain Res 284 (1983), 343-371.
42. R. Minkeviciene, P. Banerjee and H. Tanila, Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease, J Pharmacol Exp Ther 311 (2004), 677-682.
43. R. Mistry, R. Wilke and R.A. Challiss, Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex, Br J Pharmacol 114 (1995), 797-804.
44. S. Nakamura, N. Murayama, T. Noshita, R. Katsuragi and T. Ohno, Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801, Eur J Pharmacol 548 (2006), 115-122.
45. L. Nowak, P. Bregestovski, P. Ascher, A. Herbet and A. Prochiantz, Magnesium gates glutamate-activated channels in mouse central neurones, Nature 307 (1984), 462-465.
46. D. Oliver, J. Ludwig, E. Reisinger, W. Zoellner, J.P. Ruppersberg and B. Fakler, Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells, Mol Pharmacol 60 (2001), 183-189.
47. C.G. Parsons, W. Danysz and G. Quack, Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-a review of preclinical data, Neuropharmacol 38 (1999), 735-767.
48. C.G. Parsons, V.A. Panchenko, V.O. Pinchenko, A.Y. Tsyndrenko and O.A. Krishtal, Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine, Eur J Neurosci 8 (1996), 446-454.
49. E.F. Pereira, C. Hilmas, M.D. Santos, M. Alkondon, A. Maelicke and E.X. Albuquerque, Unconventional ligands and modulators of nicotinic receptors, J Neurobiol 53 (2002), 479-500.
50. E.K. Perry, The cholinergic hypothesis - ten years on, Br Med Bull 42 (1986), 63-69.
51. R. Pohorecki, R. Head and E.F. Domino, Effects of selected muscarinic cholinergic antagonists on [3H]acetylcholine release from rat hippocampal slices, J Pharmacol Exp Ther 244 (1988), 213-217.
52. G. Rammes, R. Rupprecht, U. Ferrari, W. Zieglgansberger and C.G. Parsons, The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkylcyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner, Neurosci Lett 306 (2001), 81-84.
53. T.H. Rammsayer, Effects of pharmacologically induced changes in NMDA receptor activity on human timing and sensorimotor performance, Brain Res 1073-1074 (2006), 407-416.
54. G. Reiser and R. Koch, Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line, Eur J Pharmacol 172 (1989), 199-203.
55. G. Riedel, Function of metabotropic glutamate receptors in learning and memory, Trends Neurosci 19 (1996), 219-224.
56. G. Riedel, B. Platt and J. Micheau, Glutamate receptor function in learning and memory, Behav Brain Res 140 (2003), 1-47.
57. L. Robinson, D. Harbaran and G. Riedel, Visual acuity in the water maze: sensitivity to muscarinic receptor blockade in rats and mice, Behav Brain Res 151 (2004), 277-286.
58. E.v.L. Roloff, D. Harbaran, J. Micheau, B. Platt and G. Riedel, Dissociation of cholinergic function in spatial and procedural learning in rats, Neurosci 146 (2007), 875-889.
59. S.T. Rouse, S.M. Edmunds, H. Yi, M.L. Gilmor and A.I. Levey, Localization of M2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus, Neurosci Lett 284 (2000), 182-186.
60. D. Ryan, A.J. Drysdale, R.G. Pertwee and B. Platt, Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue, Eur J Neurosci 25 (2007), 2093-2102.
61. A. Salmon, C. Erb, E. Meshorer, D. Ginzberg, Y. Adani, I. Rabinovitz, G. Amitai and H. Soreq, Muscarinic modulations of neuronal anticholinesterase responses, Chem Biol Interact 157-158 (2005), 105-113.
62. F.A. Schmitt, C.H. van Dyck, C.H. Wichems and J.T. Olin, Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis, Alzheimer Dis Assoc Disord 20 (2006), 255-262.
63. M.M. Schugens, R. Egerter, I. Daum, K. Schepelmann, T. Klockgether and P.A. Loschmann, The NMDA antagonist memantine impairs classical eyeblink conditioning in humans, Neurosci Lett 224 (1997), 57-60.
64. H.L. Scott, D.V. Pow, A.E. Tannenberg and P.R. Dodd, Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease, J Neurosci 22 (2002), 1-5.
65. T. Seeger, I. Fedorova, F. Zheng, T. Miyakawa, E. Koustova, J. Gomeza, A.S. Basile, C. Alzheimer and J. Wess, M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity, J Neurosci 24 (2004), 10117-10127.
66. E. Shearman, S. Rossi, B. Szasz, Z. Juranyi, S. Fallon, N. Pomara, H. Shershen and A. Lajtha, Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administration: A microdialysis study, Brain Res Bull 69 (2006), 204-213.
67. Y. Shimoshige, T. Maeda, S. Kaneko, A. Akaike and M. Satoh, Involvement of M2 receptor in an enhancement of long-term potentiation by carbachol in Schaffer collateral-CA1 synapses of hippocampal slices, Neurosci Res 27 (1997), 175-180.
68. T. Shinoe, M. Matsui, M.M. Taketo and T. Manabe, Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus, J Neurosci 25 (2005), 11194-11200.
69. D. Van Dam, D. Abramowski, M. Staufenbiel and P.P. De Deyn, Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model, Psychopharmacol 180 (2005), 177-190.
70. D. VanDamand P.P. De Deyn, Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model, Eur Neuropsychopharmacol 16 (2006), 59-69.
71. M.T. Vilaro, G. Mengod and J.M. Palacios, Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors, Prog Brain Res 98 (1993), 95-101.
72. G.L. Wenk, W. Danysz and S.L. Mobley, MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis, Eur J Pharmacol 293 (1995), 267-270.
73. G.L. Wenk, W. Danysz and S.L. Mobley, Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat, Brain Res 655 (1994), 7-11.
74. G.L. Wenk, G. Quack, H.J. Moebius and W. Danysz, No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use, Life Sci 66 (2000), 1079-1083.
75. K. Yamada, M. Takayanagi, H. Kamei, T. Nagai, M. Dohniwa, K. Kobayashi, S. Yoshida, T. Ohhara, K. Takuma and T. Nabeshima, Effects of memantine and donepezil on amyloid beta-induced memory impairment in a delayed-matching to position task in rats, Behav Brain Res 162 (2005), 191-199.
76. W. Zajaczkowski, T. Frankiewicz, C.G. Parsons and W. Danysz, Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP, Neuropharmacol 36 (2005), 961-971.
77. W. Zajaczkowski, G. Quack and W. Danysz, Infusion of (+) -MK-801 and memantine - contrasting effects on radial maze learning in rats with entorhinal cortex lesion, Eur J Pharmacol 296 (1996), 239-246.
78. P.R. Zoladz, A.M. Campbell, C.R. Park, D. Schaefer, W. Danysz and D.M. Diamond, Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane, Pharmacol Biochem Behav 85 (2006), 298-306.